UPEXI, INC. (UPXI) - Dilution Analysis

10-Q filing | 65.5M shares outstanding

S-3 filing: Upexi, Inc. is filing an S-3 registration statement to offer up to $1,000,000,000 of common stock, preferred stock, debt securities, warrants, and units.

8-K filing: Upexi, Inc. completed a private placement offering on December 1, 2025, selling 3,289,474 shares of common stock and warrants to purchase up to 3,289,474 shares of common stock for gross proceeds of $10 million. ($10.0M proceeds)

10-Q filing | 55.3M shares outstanding

S-1/A filing: This prospectus relates to the offer and sale from time to time by A.G.P./Alliance Global Partners of up to 83,333,333 shares of our common stock pursuant to a common stock purchase agreement.

S-1/A filing: This preliminary prospectus relates to the offering and potential resale by the selling stockholders of up to 12,457,186 shares of common stock and 35,569,224 shares of common stock issuable upon the conversion of $151,169,169 in aggregate principal amount of Secured Convertible Notes.

S-1/A filing: This preliminary prospectus relates to the offering and potential resale by the selling stockholders of up to 12,457,186 shares of common stock and also covers the offer and potential resale of 35,569,224 shares of our Common Stock issuable upon the conversion of $151,169,169 in aggregate principal amount of Secured Convertible Notes.

S-1/A filing: This prospectus relates to the offer and sale from time to time by A.G.P./Alliance Global Partners of up to 83,333,333 shares of common stock that may be issued to the Selling Stockholder pursuant to a common stock purchase agreement.

S-1/A filing: This S-1/A filing relates to the offer and sale of up to 83,333,333 shares of common stock by the selling stockholder, A.G.P./Alliance Global Partners, pursuant to a common stock purchase agreement.

S-1/A filing: This preliminary prospectus relates to the offering and potential resale by the selling stockholders of up to 12,457,186 shares of common stock of Upexi, Inc., which consists of 12,457,186 shares of Common Stock issued to the investors of the PIPE, pursuant to that certain Securities Purchase Agreement, dated July 11, 2025, by and between the Company and certain of the Selling Stockholders.

S-1/A filing: This S-1/A filing registers the offer and sale of up to 83,333,333 shares of common stock by a selling stockholder pursuant to a common stock purchase agreement.

S-1/A filing: This preliminary prospectus relates to the offering and potential resale by the selling stockholders of up to 12,457,186 shares of common stock, $0.001 par value of Upexi, Inc., which consists of 12,457,186 shares of Common Stock issued to the investors of the PIPE, pursuant to that certain Securities Purchase Agreement, dated July 11, 2025. Additionally, this preliminary prospectus also covers the offer and potential resale of 35,569,224 shares of our Common Stock issuable upon the conversion of $151,169,169 in aggregate principal amount of Secured Convertible Notes, pursuant to certain purchase agreements, dated July 16, 2025.

S-1/A filing: This preliminary prospectus relates to the offering and potential resale by the selling stockholders of up to 12,457,186 shares of common stock and the offer and potential resale of 35,569,224 shares of common stock issuable upon the conversion of $151,169,169 in aggregate principal amount of Secured Convertible Notes.

S-1/A filing: This prospectus relates to the offer and sale from time to time by A.G.P./Alliance Global Partners of up to 83,333,333 shares of common stock that may be issued pursuant to a common stock purchase agreement.

S-1 filing: This prospectus relates to the offer and sale from time to time by A.G.P./Alliance Global Partners of up to 83,333,333 shares of our common stock.

S-1/A filing: This S-1/A filing discusses the potential resale of up to 12,457,186 shares of common stock and 35,569,224 shares of common stock issuable upon conversion of secured convertible notes.

S-1 filing: This preliminary prospectus relates to the offering and potential resale by the selling stockholders of up to 12,457,186 shares of common stock, $0.001 par value of Upexi, Inc. and also covers the offer and potential resale of 35,569,224 shares of our Common Stock issuable upon the conversion of $151,169,169 in aggregate principal amount of Secured Convertible Notes.

8-K filing: Upexi, Inc. announced the closing of a private placement equity offering of 12,457,186 shares of common stock with certain investors, including the Company's CEO and a Director, at a price of $4.00 per share (and $4.94 per share for Management and Board participation) for aggregate gross proceeds of approximately $50 million. ($50.0M proceeds)

8-K filing: Upexi, Inc. closed a private placement offering on July 14, 2025, issuing 12,457,186 shares of common stock at $4.00 per share (and at a price of $4.94 per share for certain members of the Company's Management and Board of Directors), resulting in aggregate gross proceeds of $50 million before deducting fees and expenses, with A.G.P/Alliance Global Partners acting as the sole placement agent. ($50.0M proceeds)

8-K filing: Upexi, Inc. entered into securities purchase agreements for the purchase and sale of 12,457,186 shares of common stock (or common stock equivalents) at a price of $4.00 per share (and $4.94 per share for management) for gross proceeds of approximately $50 million. ($50.0M proceeds)

S-1/A filing: This prospectus relates to the offering and resale by the Selling Stockholder identified herein of up to 43,859,649 shares of common stock of Upexi, Inc.

S-1 filing: This S-1 filing is for an offering and resale of up to 43,859,649 shares of common stock of Upexi, Inc., consisting of PIPE Shares and shares issuable upon exercise of Pre-Funded Warrants.

10-Q filing | 1.0M shares outstanding

8-K filing: Upexi, Inc. announced that it has increased its treasury of Solana to approximately 201,500 Solana (SOL) tokens for $30 million, or $148.47 per SOL. ($30.0M proceeds)

8-K filing: Upexi, Inc. closed a private placement offering on April 24, 2025, selling 35,970,383 shares of common stock at $2.28 per share and pre-funded warrants to purchase 7,889,266 shares at $2.279 per warrant, for aggregate gross proceeds of $100 million.

8-K filing: Upexi, Inc. announced it has entered into securities purchase agreements for the purchase and sale of 43,859,649 shares of common stock at a price of $2.28 per share for aggregate gross proceeds of approximately $100 million. ($100.0M proceeds)

10-Q filing | 1.0M shares outstanding

10-Q filing | 1.0M shares outstanding

10-K filing | 1.0M shares outstanding

8-K filing: Stock split 1-for-20 | Outstanding: 20,906,870 → 1,040,886

10-Q filing | 20.9M shares outstanding

10-Q filing | 20.4M shares outstanding

10-Q filing | 20.2M shares outstanding

10-K filing | 20.2M shares outstanding

10-Q filing | 18.0M shares outstanding

8-K filing: Upexi, Inc. entered into a securities purchase agreement to issue and sell 2,121,213 shares of common stock at $3.30 per share in a registered direct offering, with gross proceeds of approximately $7 million before deducting fees and expenses; also issuing warrants to placement agents to purchase up to 8.0% of the shares sold in the offering at an exercise price of $4.774 per share. ($7.0M proceeds)

10-Q filing | 17.5M shares outstanding

POS AM filing: This Post-Effective Amendment relates to the Registration Statement on Form S-3 registering 1,118,574 shares of Upexi's common stock for resale.

10-Q filing | 16.7M shares outstanding

8-K filing: Upexi, Inc. acquired E-Core Technology, Inc. by purchasing 100% of its stock, with consideration including cash, common stock, and promissory notes. ($6.0M proceeds)

8-K filing: Upexi, Inc. sold 100% of the membership interests of Infusionz LLC to Bloomios, Inc. and its subsidiary Infused Confections LLC for $23,500,000, consisting of cash, a promissory note, preferred stock, a debenture, and a common stock purchase warrant. ($8.5M proceeds)

10-K filing | 16.2M shares outstanding

S-3 filing: This S-3 filing relates to the resale of 1,118,574 shares of common stock by selling stockholders, consisting of shares issuable upon conversion of convertible promissory notes and shares issuable upon exercise of common stock purchase warrants.

S-3 filing: The filing is for a shelf registration of common stock, preferred stock, warrants, and/or units up to an aggregate of $30,000,000.

10-Q filing | 16.4M shares outstanding

8-K filing: Grove Inc. purchased 55% of the outstanding membership interests of Cygnet Online, LLC for $6,050,000, including $2,550,000 payable in 555,489 shares of restricted common stock and a $2,000,000 convertible promissory note. ($2.55M proceeds)

8-K filing: Grove, Inc. completed the first stage of its repurchase program, buying back 467,765 shares of its common stock at an average price of $4.22 per share, totaling $1,974,896. ($1.97M proceeds)

10-Q filing | 16.4M shares outstanding

10-Q filing | 15.5M shares outstanding

8-K filing: Grove Inc. acquired Interactive Offers, LLC for $6,100,000, consisting of 666,667 shares of common stock and a cash payment of $2,100,000.

8-K filing: Grove, Inc. authorized a stock repurchase program to repurchase up to 1,000,000 shares of its common stock.

10-K filing | 15.7M shares outstanding

8-K filing: Grove Inc. entered into an Asset Purchase Agreement to purchase substantially all of the assets of VitaMedica Corporation for $2,000,000 in cash, $500,000 of Grove's common stock, a $500,000 promissory note, and a $500,000 convertible promissory note convertible into 100,000 shares of Grove Common Stock at $5.00 per share.

8-K filing: Grove, Inc. completed a firm commitment underwritten initial public offering of 2,530,000 shares of common stock at $5.00 per share, resulting in gross proceeds of approximately $12.65 million, and issued a warrant to purchase 50,600 shares of common stock to the underwriter's representative. ($12.65M proceeds)

S-1/A filing: Registration of shares of common stock underlying underwriters' warrants.

S-1/A filing: This S-1/A filing from June 2, 2021, details an offering of 2,200,000 shares of common stock at an assumed price of $5.00 per share, with an over-allotment option for underwriters to purchase an additional 330,000 shares; the company intends to use the net proceeds for purchasing production equipment, building improvements, potential acquisitions, hiring new personnel, marketing, research and development and working capital.

S-1/A filing: This S-1/A filing details an offering of 2,200,000 shares of common stock, with an over-allotment option for underwriters to purchase an additional 330,000 shares, at an assumed price of $5.00 per share, with the intent to use the proceeds for various business purposes.

S-1/A filing: This S-1/A filing relates to an offering of common stock with an over-allotment option for additional shares. The company intends to use the net proceeds from this offering for working capital and general corporate purposes, including acquisitions.